Effect of Dienogest therapy on the size of the endometrioma

References

• Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24(2):235–258.
   PubMed Web of Science ®Google Scholar
• Farquhar C. Endometriosis. Clin Evid; 2004;(11):2391–2405.
   Google Scholar
• National Institute for Health and Care Excellence. Endometriosis: diagnosis and management (NICE guideline 37); 2017. [cited 2020 Feb 06]. Available from: www.nice.org.uk/guidance/ng37.
   Google Scholar
• Dunselman GA, Vermeulen N, Becker C, et al. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.
   PubMed Web of Science ®Google Scholar
• Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146–3154.
   PubMed Web of Science ®Google Scholar
• Busacca M, Marana R, Caruana P, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Am J Obstet Gynecol. 1999;180(3 Pt 1):519–523.
   PubMed Web of Science ®Google Scholar
• Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738–743.
   PubMed Web of Science ®Google Scholar
• KöHler G, Faustmann TA, Gerlinger C, et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. Int J Gynaecol Obstet Int J Gynaecol Obstet. 2010;108(1):21–25.
   PubMed Web of Science ®Google Scholar
• Momoeda M, Harada T, Terakawa N, et al. Long-term use of dienogest for the treatment of endometriosis. J. Obstet. Gynaecol. 2009;35(6):1069–1076.
   Google Scholar
• Sugimoto K, Nagata C, Hayashi H, et al. Use of dienogest over 53 weeks for the treatment of endometriosis. J Obstet Gynaecol. 2015;41(12):1921–1926
   Google Scholar
• Del Forno S, Mabrouk M, Arena A, et al. Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?. Eur J Obstet Gynecol Reprod Biol. 2019; 238:120–124.
   PubMed Web of Science ®Google Scholar
• Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2019;36:1–3.
   PubMed Web of Science ®Google Scholar
• Muzii L, Galati G, Di Tucci C, et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2019;36(1):81–83.
   PubMed Web of Science ®Google Scholar
• Van Holsbeke C, Van Calster B, Guerriero S, et al. Endometriomas: their ultrasound characteristics. Ultrasound Obstet Gynecol. 2010;35(6):730–740.
   PubMed Web of Science ®Google Scholar
• Busacca M, Vignali M. Ovarian endometriosis: from pathogenesis to surgical treatment. Curr Opin Obstet Gynecol. 2003;15(4):321–326.
   PubMed Web of Science ®Google Scholar
• Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol. 1986;67(3):335–338.
   PubMed Web of Science ®Google Scholar
• Redwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999;72:310–315.
   PubMed Web of Science ®Google Scholar
• Busacca M, Riparini J, Somigliana E, et al. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol. 2006;195(2):339–340.
   PubMed Web of Science ®Google Scholar
• Coccia ME, Rizzello F, Mariani G, et al. Ovarian surgery for bilateral endometriomas influences age at menopause. Hum Reprod. 2011;26(11):3000–3007.
   PubMed Web of Science ®Google Scholar
• Sugita A, Iwase A, Goto M, et al. One-year follow-up of serum antimullerian hormone levels in patients with cystectomy: Are different sequential changes due to different mechanisms causing damage to the ovarian reserve?. Fertil Steril. 2013;100:516–522.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Berlanda N, Benaglia L, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril. 2012;98:1531–1538.
   PubMed Web of Science ®Google Scholar
• Muzii L, Bianchi A, Croce C, et al. Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril. 2002;77(3):609–614.
   PubMed Web of Science ®Google Scholar
• Hachisuga T, Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod. 2002;17(2):432–435.
   PubMed Web of Science ®Google Scholar
• Benaglia L, Somigliana E, Vighi V, et al. Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod. 2010;25(3):678–682.
   PubMed Web of Science ®Google Scholar
• Vignali M, Mabrouk M, Ciocca E, et al. Surgical excision of ovarian endometriomas: Does it truly impair ovarian reserve? Long term anti-Müllerian hormone (AMH) changes after surgery. J Obstet Gynaecol Res. 2015;41(11):1773–1778.
   PubMed Web of Science ®Google Scholar
• Goodman LR, Goldberg JM, Flyckt RL, et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016; 215(5):589.e1–589.e6
   Web of Science ®Google Scholar
• Sanchez AM, Vigano P, Somigliana E, et al. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20: 217–230.
   PubMed Web of Science ®Google Scholar
• Leone Roberti Maggiore U, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol. 2017; 209:81–85.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li XH, Ma X, et al. Redox-induced apoptosis of human oocytes in resting follicles in vitro. J Soc Gynecol Investig. 2006; 13(6):451–458.
   PubMedGoogle Scholar
• Maneschi F, Marasa L, Incandela S, et al. Ovarian cortex surrounding benign neoplasms: a histologic study. Am J Obstet Gynecol. 1993; 169(2 Pt 1):388–393.
   PubMed Web of Science ®Google Scholar
• Kuroda KK, Arakawa A, Fukumura Y, et al. Histological assessment of impact of ovarian endometrioma and laparoscopic cystectomy on ovarian reserve. J Obstet Gynaecol Res. 2012; 38(9):1187–1193.
   PubMed Web of Science ®Google Scholar
• Qiu JJ, Liu YL, Liu MH, et al. Ovarian interstitial blood flow changes assessed by transvaginal colour Doppler sonography: predicting ovarian endometrioid cyst-induced injury to ovarian interstitial vessels. Arch Gynecol Obstet. 2012; 285(2):427–433.
   PubMed Web of Science ®Google Scholar
• Muzii L, Di Tucci C, Di Feliciantonio M, et al. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014; 29(12):2854–2855.
   PubMedGoogle Scholar
• KasapogluI AB, Uyaniklar O, Seyhan A, et al. Endometrioma-related reduction in ovarian reserve: a prospective longitudinal study. Fertil Steril. 2018; 110(1):122–127FS.
   PubMed Web of Science ®Google Scholar
• Muzii L, Di Tucci C, Di Feliciantonio M, et al. Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis. Fertil Steril. 2018;110(5):856–857.
   PubMed Web of Science ®Google Scholar
• Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15: 441–461.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani PG, Abbiati A, et al. The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update. 2009; 15(2):177–188.
   PubMed Web of Science ®Google Scholar
• Busacca M, Chiaffarino F, Candiani M, et al. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am J Obstet Gynecol. 2006; 195(2):426–432.
   PubMed Web of Science ®Google Scholar
• Kohler G, Faustmann TA, Gerlinger C, et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. Int J Gynaecol Obstet. 2010; 108(1):21–25.
   PubMed Web of Science ®Google Scholar
• Mueck AO. Dienogest: an oral progestogen for the treatment of endometriosis. Expert Rev Obstet Gynecol. 2011;6(1):5–15.
   Google Scholar
• Strowitzki T, Faustmann T, Gerlinger C, et al. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Womens Health. 2015;7:393–401.
   PubMed Web of Science ®Google Scholar
• Römer T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet. 2018;298(4):747–753.
   PubMed Web of Science ®Google Scholar
• Park SY, Kim SH, Chae HD, et al. Efficacy and safety of dienogest in patients with endometriosis: a single-center observational study over 12 months. Clin Exp Reprod Med. 2016;43(4):215.
   PubMedGoogle Scholar
• Muneyyirci-Delale O, Anopa J, Charles C, et al. Medical management of recurrent endometrioma with long-term norethindrone acetate. Int J Womens Health. 2012;4:149–154.
   PubMedGoogle Scholar
• Harada T, Momoeda M, Taketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90(5):1583–1588.
   PubMed Web of Science ®Google Scholar
• Harada T, Kosaka S, Elliesen J, et al. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial. Fertil Steril. 2017;108(5):798–805.
   PubMed Web of Science ®Google Scholar
• Agarwal SK, Foster WG. Reduction in endometrioma size with three months of aromatase inhibition and progestin add-back. Biomed Res Int. 2015;2015:1–4.
   Web of Science ®Google Scholar
• Barra F, Grandi G, Tantari M, et al. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opin Biol Ther. 2019;15(2): 276–281.
   Google Scholar
• Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril. 2017;107(3):533–536.
   PubMed Web of Science ®Google Scholar
• Sokalska A, Timmerman D, Testa AC, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol. 2009;34(4):462–470.
   PubMed Web of Science ®Google Scholar